Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?
Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?
Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?
Submitted by
admin
on January 28, 2022 - 10:17am
Source:
Motley Fool
News Tags:
Pfizer
abrocitinib
atopic dermatitis
Headline:
Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?
snippet:
The FDA recently approved abrocitinib as a treatment for atopic dermatitis.
In the past, Pfizer has predicted the medicine could generate peak annual sales of around $3 billion.
However, abrocitinib's approval as a second-line treatment could limit its market opportunity.
Do Not Allow Advertisers to Use My Personal information